JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-05-15 ms8000001582516092 来自福建省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：MEta;肿瘤
经验分享：第二天秒拒

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-03-18 1489114dm38(暂无昵称) 来自四川省

偏重的研究方向：肿瘤
经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited

47 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-08-22 我缺一套剑法来自辽宁省

请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-08-19 ms4000000681775086 来自福建省

请问想催稿，但是不知道在哪找编辑邮箱

22 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-04-27 ms1000000056011696 来自广东省

找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家

35 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-08-16 w666

投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家

18 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-07-25 ms4000001131300035 来自四川省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂

30 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-04-24 ms3000001362053617 来自江西省

1 Reviewer(s) accepted about 18 hours ago
几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？

28 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-08-10 ms2000002031951446 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：meta分析;胃癌
经验分享：Publishing and rights
Submission status Date
Publishing and rights complete
07 Jul 2023
Submission is in publishing and rights
07 Jul 2023
Peer review
Submission status Date
Submission accepted
30 Jun 2023
Submission under peer review
28 Jun 2023
Submission passed technical check
28 Jun 2023
Revision received
28 Jun 2023
Submission under peer review
25 May 2023
Technical check
Submission status Date
Submission passed technical check
25 May 2023
Amendment received
24 May 2023
Submission is under technical check
23 May 2023
Submission received
Submission status Date
Submission received
23 May 2023

感恩！

22 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2134811, encodeId=7fd4213481179, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：MEta;肿瘤 经验分享：第二天秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69a08686224, createdName=ms8000001582516092, createdTime=Mon May 15 20:45:36 CST 2023, time=2023-05-15, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120358, encodeId=97b6212035869, content=偏重的研究方向：肿瘤 经验分享：记录一下自己的下投稿经历，希望文章接受 2023-3-18 submitted 2023-3-18 14 reviewers invited, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Mar 18 23:29:22 CST 2023, time=2023-03-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2154049, encodeId=f266215404903, content=请问杂志的版面费多少，纯生信有公共数据库验证无实验验证收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Tue Aug 22 14:09:08 CST 2023, time=2023-08-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153555, encodeId=31cc2153555d5, content=请问想催稿，但是不知道在哪找编辑邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Sat Aug 19 09:11:41 CST 2023, time=2023-08-19, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2128620, encodeId=b1d72128620c2, content=找不到审稿人，能联系编辑再多邀请几位审稿人吗？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72446462907, createdName=ms1000000056011696, createdTime=Thu Apr 27 09:44:37 CST 2023, time=2023-04-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153024, encodeId=d8ed2153024ab, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：想问下大家，一个多月没邀请到审稿人了，能发邮件催一下不，邮件应该怎么写呢，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/11/671d05e8fa9bf8bc486a2adebeb80dd1.jpg, createdBy=f6bc5075954, createdName=w666, createdTime=Wed Aug 16 12:02:00 CST 2023, time=2023-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149793, encodeId=fce92149e93d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问大家，我投稿显示Technical check passed 21 Jul 23 Ready to be assigned to an editor.点进详情里面又是Your submission has passed the technical checks and is now in peer review。We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.这一步到底是在分编辑还是已经送外审了呀，纯纯看不懂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6c6396308, createdName=ms4000001131300035, createdTime=Tue Jul 25 19:57:11 CST 2023, time=2023-07-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128098, encodeId=30d7212809858, content=1 Reviewer(s) accepted about 18 hours ago 几天前就已经显示有一个审稿人了,今天时间突然又变了，但是审稿人数却没有增加，这是咋回事啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=599a8366835, createdName=ms3000001362053617, createdTime=Mon Apr 24 17:57:25 CST 2023, time=2023-04-24, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2152138, encodeId=deab2152138e5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：meta分析;胃癌 经验分享：Publishing and rights Submission status Date Publishing and rights complete 07 Jul 2023 Submission is in publishing and rights 07 Jul 2023 Peer review Submission status Date Submission accepted 30 Jun 2023 Submission under peer review 28 Jun 2023 Submission passed technical check 28 Jun 2023 Revision received 28 Jun 2023 Submission under peer review 25 May 2023 Technical check Submission status Date Submission passed technical check 25 May 2023 Amendment received 24 May 2023 Submission is under technical check 23 May 2023 Submission received Submission status Date Submission received 23 May 2023 感恩！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c788152685, createdName=ms2000002031951446, createdTime=Thu Aug 10 17:37:55 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152115, encodeId=a9ff215211552, content=审稿速度:1.0 偏重的研究方向：肿瘤;临床 经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1a86568813, createdName=ms6000000133179155, createdTime=Thu Aug 10 16:22:02 CST 2023, time=2023-08-10, status=1, ipAttribution=山东省)]

2023-08-10 ms6000000133179155 来自山东省

审稿速度:1.0
偏重的研究方向：肿瘤;临床
经验分享：技术审查倒是挺快的。20天了，状态还是8 Reviewer(s) invited。看评论说这是没有邀请到审稿人，编辑也没再联系，好慌啊...

19 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务